CN103860699A - Pharmaceutical composition for radically treating hypertension, hyperlipidemia and hyperglycemia - Google Patents
Pharmaceutical composition for radically treating hypertension, hyperlipidemia and hyperglycemia Download PDFInfo
- Publication number
- CN103860699A CN103860699A CN201410040736.1A CN201410040736A CN103860699A CN 103860699 A CN103860699 A CN 103860699A CN 201410040736 A CN201410040736 A CN 201410040736A CN 103860699 A CN103860699 A CN 103860699A
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- radix
- herba
- hypers
- pedicellus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a pharmaceutical composition for radically treating hypertension, hyperlipidemia and hyperglycemia. The pharmaceutical composition for radically treating hypertension, hyperlipidemia and hyperglycemia is prepared from 15-25 parts of water chestnuts, 0.5-2 parts of sculellaria barbata and 0.5-2 parts of oldenlandia diffusa. The pharmaceutical composition provided by the invention can be used for preventing hypertension, hyperlipidemia and hyperglycemia. The hypertension, hyperlipidemia and hyperglycemia can be radically treated after the harmaceutical composition is continuously taken for 1 year. The pharmaceutical composition provided by the invention further has a certain curative effect to cancers.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, relate in particular to a kind of for effecting a radical cure the pharmaceutical composition of three-hypers.
Background technology
Three-hypers is the general name of hyperlipidemia, hypertension, hyperglycemia.Research shows that the gathering of this three's clinical disease is not accidental.Within 1988, famous American endocrine expert Reaven is by the insulin resistant in hyperglycemia, hyperinsulinemia, impaired glucose tolerance, hypertriglyceridemia and hypertension in hyperlipidemia are referred to as " X syndrome ", i.e. present medical circle metabolism syndrome in general.
Doctor trained in Western medicine does not have good way to three-hypers, can only reach the object of controlling disease relief of symptoms.Once often follow all the life ill, Drug therapy innovations in pattern or design, drug dose are more and more, and not only three-hypers disease could not be cured, the toxic and side effects of medicine also grievous injury the function of the important organs such as liver, kidney, eye, the heart, directly affect quality of life.
This goes to solve three-hypers problem with regard to forcing us to go to analyze from the angle of the traditional Chinese medical science.
Summary of the invention
The present invention will solve three-hypers problem, thereby provides a kind of for effecting a radical cure the pharmaceutical composition of three-hypers.
The present invention addresses the above problem, and following technical scheme is provided:
For effecting a radical cure a pharmaceutical composition for three-hypers, formed by Pedicellus et Pericarpium Trapae 15～25 weight portions, Herba Scutellariae Barbatae 0.5～2 weight portion and Herba Hedyotidis Diffusae 0.5～2 weight portion.
As technique scheme preferably, Pedicellus et Pericarpium Trapae 18～22 weight portions, Herba Scutellariae Barbatae 0.8～1.5 weight portion and Herba Hedyotidis Diffusae 0.8～1.5 weight portion.
As technique scheme preferably, Pedicellus et Pericarpium Trapae 19～21 weight portions, Herba Scutellariae Barbatae 0.8～1.2 weight portion and Herba Hedyotidis Diffusae 0.8～1.2 weight portion.
As technique scheme preferably, Pedicellus et Pericarpium Trapae 20 weight portions, Herba Scutellariae Barbatae 1 weight portion and Herba Hedyotidis Diffusae 1 weight portion.
As technique scheme preferably, Pedicellus et Pericarpium Trapae 20g, Herba Scutellariae Barbatae 1g and Herba Hedyotidis Diffusae 1g.
Aforementioned pharmaceutical compositions of the present invention is a kind of pharmaceutical composition using in the mode of health product for general population or the not serious crowd of three high level.
Taking aforementioned pharmaceutical compositions can prevent three-hypers to alleviate three-hypers.
Distinct with Western medicine, Chinese medicine has Biphasic Regulation to blood pressure, and hypertension person can reduce, and blood pressure low person can raise.As Radix Ginseng, Cornu Cervi Pantotrichum, the Radix Paeoniae Alba, Fructus Schisandrae Chinensis, Radix Rhodiolae, Bulbus Fritillariae Thunbergii, Rhizoma Atractylodis, Rhizoma Zingiberis, Fructus Evodiae, Herba Asari, Calculus Bovis, the Radix Aucklandiae, Semen Sinapis Albae, Radix Salviae Miltiorrhizae, Herba Leonuri, Sargassum, Herba Agrimoniae, Ilex purpurea Hassk.[I.chinensis Sims etc.This adaptogen is characteristics of Traditional Chinese Medicine.
Normally used depressor has: Radix Angelicae Pubescentis, Fructus Xanthii, Flos Magnoliae, Flos Chrysanthemi, Folium Mori etc. in diaphoretic medicine; Rhizoma Coptidis, Radix Scrophulariae, Spica Prunellae, Herba Lobeliae Chinensis, Flos Chrysanthemi Indici, Cortex Phellodendri etc. in antipyretic; Radix Et Rhizoma Rhei, Radix Phytolaccae, the Radix Euphorbiae Pekinensis, Flos Genkwa etc. in cathartic drug; Radix Angelicae Pubescentis, Radix Cynanchi Paniculati, Herba Artemisiae Scopariae, Cortex Magnoliae Officinalis, Herba Dianthi, Herba Polygoni Avicularis etc. in damp eliminating medicine; Radix Aconiti Lateralis Preparata, Radix Aconiti, Fructus Piperis Longi etc. in drugs for dispelling internal cold; Rhizoma Cyperi, Lignum Aquilariae Resinatum, Radix Aristolochiae etc. in QI regulating medicine; Flos Carthami, Herba Leonuri, Caulis Spatholobi, Radix Notoginseng, Rhizoma Chuanxiong, Rhizoma Corydalis, Radix Cirsii Japonici etc. in blood-regulating drug; Radix Platycodonis, Radix Peucedani, Semen Ginkgo, Semen Armeniacae Amarum etc. in apophlegmatisant; Cornu Saigae Tataricae, Ramulus Uncariae Cum Uncis, Pheretima etc. in liver-pacifying medicinal; The Radix Rehmanniae, Radix Angelicae Sinensis, Herba Epimedii, the Rhizoma Atractylodis Macrocephalae, the Radix Astragali, Semen Cuscutae, the Cortex Eucommiae etc. in drug supporting healthy energy.
The Chinese medicine that can reduce serum cholesterol has: Semen Cassiae, the Radix Polygoni Multiflori, Fructus Rosae Laevigatae, Rhizoma Alismatis, Radix Curcumae, the Radix Rehmanniae, Folium Mori, Radix Bupleuri, Rhizoma Cimicifugae, Radix Scutellariae, Rhizoma Coptidis, Bi, Flos Sophorae, Radix Salviae Miltiorrhizae, Thallus Laminariae (Thallus Eckloniae), Radix Changii, Ganoderma, Rhizoma Polygonati, Fructus Lycii, Fructus Ligustri Lucidi, Radix Et Rhizoma Rhei, Fructus Cannabis, Herba Artemisiae Scopariae, Fructus Perillae etc.Separately there is the Chinese medicine being of little use also to have the effect of good reduction serum cholesterol, as Herb Gynostemmae Pentaphylli, Folium Ilicis, Radix Oenotherae erythrosepalae etc.
The Chinese medicine that reduces serum triglycerides has: Radix Panacis Quinquefolii, Folium Ginkgo, Cordyceps, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, Rhizoma Drynariae, Caulis Polygoni Multiflori, Fructus Ligustri Lucidi, Semen Astragali Complanati, Radix Cynanchi Auriculati, Radix Rehmanniae Preparata, Radix Camelliae sinensis, Maifanitum etc.
Atherosclerosis, comprises that the Chinese medicine that dissolves speckle on arterial wall has: Fructus Lycii, Rhizoma Cimicifugae, Radix Paeoniae Rubra, Caulis Lonicerae, Radix Stellariae, Rhizoma Smilacis Glabrae, Rhizoma Paridis, Radix Cynanchi Paniculati, Herba Taxilli, Pollen Typhae, Myrrha, Radix Ilicis Pubescentis, Radix Salviae Miltiorrhizae, Herba Cistanches, Radix Angelicae Sinensis, Fructus Rosae Laevigatae, Herba Andrographis, Rhizoma Alismatis, Bi, Bulbus Allii Macrostemonis, Fructus Tribuli etc.
It is often the hidden danger of cardiovascular and cerebrovascular disease that low density lipoprotein, LDL raises, and reduction low density lipoprotein, LDL, corresponding raising high density lipoprotein are important rings of prevention cardiovascular and cerebrovascular disease.Chinese medicine can reduce having of low density lipoprotein, LDL: Folium Ginkgo, Rhizoma Polygoni Cuspidati, Semen Ziziphi Spinosae, Coriolous Dersicolor (Fr.) Quel, Fructus Perillae, Cordyceps, Folium Pini, Cornu Bubali, Acanthopanax Saponins, Folium Camelliae sinensis, Herb Gynostemmae Pentaphylli, Folium Ilicis, Radix Oenotherae erythrosepalae etc.
Can serum cholesterol-lowering, triglyceride, can have Rhizoma Polygonati, Fructus Ligustri Lucidi, Radix Changii, Radix Salviae Miltiorrhizae, Radix Curcumae, Thallus Laminariae (Thallus Eckloniae), Rhizoma Cimicifugae, Rhizoma Drynariae, Radix Glycyrrhizae, Hirudo, Rhizoma Zingiberis Recens etc. by antiatherogenic Chinese medicine again.
Falling hypoglycemic Chinese medicine has: Radix Ginseng, bosom Radix Rehmanniae, the Rhizoma Anemarrhenae, Fructus Lycii, Radix Trichosanthis, Ganoderma, Radix Panacis Quinquefolii, the Radix Paeoniae Alba, Rhizoma Polygonati, Fructus Ligustri Lucidi, Fructus Corni, Rhizoma Coptidis, Radix Scutellariae, Spica Prunellae, Cortex Phellodendri, Radix Platycodonis, Semen Armeniacae Amarum, Fructus Arctii, the Radix Aucklandiae, Chang root etc.
The Chinese medicine of dual modulation blood glucose has the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Herba Epimedii, Radix Ophiopogonis, Rhizoma Polygonati Odorati, Cortex Lycii, Radix Et Caulis Acanthopanacis Senticosi, Folium Ginseng, Herba Ephedrae, Radix Inulae etc.
To " three-hypers " all effective Chinese medicine have: Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Radix Rehmanniae Preparata, Rhizoma Polygonati Odorati, Fructus Lycii, Herba Epimedii, Ganoderma, Folium Mori, Chang root, Fructus Atriplicis Sibiricae, Radix Scutellariae, Rhizoma Coptidis, Cortex Lycii, Radix Et Rhizoma Rhei, Rhizoma Alismatis, Herba Artemisiae Scopariae, Radix Platycodonis, Thallus Laminariae (Thallus Eckloniae), Radix Notoginseng, Bulbus Allii, Stigma Maydis, Rhizoma amorphophalli, Fel Ursi, Radix Achyranthis Bidentatae, Herba Silybi mariani etc.
The traditional Chinese medical science is cured the disease exquisite dialectical, on dialectical prescription basis, select pharmacology to confirm that effective medicine is with card plus-minus according to dialectical requirement, as " three-hypers " person has deficiency of vital energy person optional with Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, deficiency of YIN person selects Radix Rehmanniae Preparata, Rhizoma Polygonati Odorati, Fructus Lycii, yang deficiency person selects Herba Epimedii, and intenseness of heat person selects Radix Scutellariae, Rhizoma Coptidis, and constipation person selects Radix Et Rhizoma Rhei etc.Will accomplish exactly dialectical prescription, pharmacology is selected medicine.
In prior art, conventionally only limit to said medicine for treatment three-hypers.And in said medicine, do not relate to Pedicellus et Pericarpium Trapae, Herba Scutellariae Barbatae and Herba Hedyotidis Diffusae.
Prior art is as follows for the report of Herba Scutellariae Barbatae:
Medicinal.Dry herb, how blade comes off, is the stem with spica and branch, and long 15～25 centimetres, four prismatics, surperficial yellow green or purple brown, smooth, matter softness, fracture is fibrous, hollow; Residual blade dark yellow-green, many fragmentations are incomplete, and shrinkage is curling, and matter is crisp and easily come off; Spica raw in branch end, yellow green.
The effect of Herba Scutellariae Barbatae
1, bacteriostasis: the dull and stereotyped trench method of Herba Scutellariae Barbatae 50% decoct, has inhibitory action to staphylococcus aureus, shigella flexneri, Bacillus typhi, bacillus pyocyaneus, escherichia coli.
2, spasmolytic phlegm-dispelling functions: the contained Flos Carthami of this product have the stronger anti-smooth muscle shrinks function being caused by histamine, and has good phlegm-dispelling functions.
3, tumor-inhibiting action: show by Mei Lanshi test tube method screening test, this product has very slight inhibitory action to Acute granulocytic leukemia cell; Show by Cellular respiration device method screening experiment, the suppression ratio of Acute granulocytic leukemia hemocyte is greater than to 75%.
4, immunoregulation effect: the contained polysaccharide of this product can promote the mouse boosting cell lymphocyte transformation of ConA induction in vitro, and its optimum concentration is 400r/ml.Sc administration can obviously improve the percentage rate of esterase positive cell in Mouse Peripheral Blood Lymphocyte after 1 week, promote the delayed allergy of DNCB induction.But heavy dose of administration (200mg/kg) can suppress mouse thymus index, on spleen index without impact.
5, alcohol formulations (200 mg/ml) all has daring and energetic cancer effect to the cancerous tissue of rectal cancer, the colon cancer etc. taked from human body in tumor tissues culture fluid; Water decoction is stablized cervical cancer cell strain separation Hela cell to cultivating has destruction.
6, with the experiment of Cellular respiration device method, leukaemia is had to more than 75% suppression ratio.
7, alcohol formulations all has the effect that suppresses its growth to Transplantable Murine sarcoma S-180, ehrlich carcinoma, cerebroma-22.
8, preserved material has hypotensive effect to animal do intravenous injection; Per os gives not produce a same purpose.
9, the ether extract of immersion has diuresis through zoopery.
10, other effect:
Suppressing ATP generates: the contained baicalin of this product has the indole-3-acetic acid oxidase of inhibition and ATP generates.
Suppress the growth of larva: and the growth of energy Heliothiszea larva.
To blood vessel function: scutellarin has increase cerebral blood flow, reduce cerebral vascular resistance, improve blood-brain barrier permeability, and the platelet aggregation effect that caused by Adenosine diphosphate work glycosides of antagonism.
Effect of Herba Scutellariae Barbatae
Herba Scutellariae Barbatae is the dry aerial parts of labiate Herba Scutellariae Barbatae, tool heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, the function such as anticancer.Main and Herba Hedyotidis Diffusae is used in conjunction with now, is used for extending the existence life-span of patients with bowel cancer.Meanwhile, Herba Scutellariae Barbatae heat clearing away, removing toxic substances, dissipating blood stasis, hemostasis, analgesic therapy, controls haematemesis, epistaxis, stranguria with blood, bloody dysentery, jaundice, has sore throat, lung abscess, furuncle, scrofula, sore, cancerous protuberance, traumatic injury knife injury, venom.
Prior art is as follows for the report of Herba Hedyotidis Diffusae:
Herba Hedyotidis Diffusae: heat and toxic materials clearing away medicine, is mainly used in the medicine of carbuncle skin infection.Sweet, light, be slightly cold.Return stomach, lung, large intestine, urinary bladder channel.Effect: heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation, promoting urination to remove dampness.Application: 1, for acute appendicitis, lung abscess, furuncle swell and ache, venom.Acute appendicitis, lung abscess, mild case is alone effectively.Furuncle swells and ache, alone or with Herba Taraxaci, Herba Violae with.Snakebite (as Trimeresurus stejnegeri bites), available the decoction of sampling wine, also can external application.2,, for various tumors, be especially used for digestive tract and lymph tumor.Alone or with the curing oncoma medicine compatibilities such as Radix Sophorae Tonkinensis, Herba Scutellariae Barbatae, Rhizoma Dioscoreae Bulbiferae.3, for damp and hot edema, pyretic stranguria, jaundice.Can be with other clearing away heat-damp and promoting diuresis, jaundice eliminating medicine with using.In addition, the modern times are again for bronchitis, pelvic inflammatory disease etc.Consumption, use are noted, are avoided 15～60 grams.Curing oncoma can be used to 120 grams.Suitable amount used externally.Research: containing hentriacontane, stigmasterol, sitosterol, maloic acid, P-coumaric acid, Herba Hedyotidis Diffusae element (may be Coumarins) flavonoid glycoside etc.The significantly immunocompetence of enhancing body, as stimulated reticuloendothelial cell hyperplasia, makes to engulf active, and enhancing antibody forms, and makes argentophile substance in the tissues such as lymph node, spleen, liver be densification change.There is antitumor action, as the tumor cell of acute lymphoblastic type, granulocyte type, monocyte type and chronic granulocyte type is had to inhibitory action; Yoshida sarcoma and ehrlich carcinoma are had to inhibitory action.Vitro antibacterial activity is not remarkable, and high concentration decoct has inhibitory action to bacillus pyocyaneus, Bacillus typhi, staphylococcus aureus, Bacillus proteus, dysentery bacterium, hemophilus influenza, streptococcus pneumoniae, Hemolytic streptococcus, Nai Shi coccus.In addition, again can adrenal cortex reinforcing function, and have analgesia, calmness, syngignoscism.
Pedicellus et Pericarpium Trapae of the present invention, except the Shell of Water Chestnut that Traditional Chinese Medicine uses, also comprises other positions of Pedicellus et Pericarpium Trapae, as the rattan net of Pedicellus et Pericarpium Trapae, the fruit of Pedicellus et Pericarpium Trapae.
Another object of the present invention is to provide another kind of for effecting a radical cure the pharmaceutical composition of three-hypers, and concrete technical scheme is as follows:
For effecting a radical cure a pharmaceutical composition for three-hypers, it is characterized in that being formed by Pedicellus et Pericarpium Trapae 45～55 weight portions, Herba Scutellariae Barbatae 0.5～2 weight portion and Herba Hedyotidis Diffusae 0.5～2 weight portion.
As technique scheme preferably, Pedicellus et Pericarpium Trapae 48～52 weight portions, Herba Scutellariae Barbatae 0.8～1.5 weight portion and Herba Hedyotidis Diffusae 0.8～1.5 weight portion.
As technique scheme preferably, Pedicellus et Pericarpium Trapae 49～51 weight portions, Herba Scutellariae Barbatae 0.8～1.2 weight portion and Herba Hedyotidis Diffusae 0.8～1.2 weight portion.
As technique scheme preferably, Pedicellus et Pericarpium Trapae 50 weight portions, Herba Scutellariae Barbatae 1 weight portion and Herba Hedyotidis Diffusae 1 weight portion.
As technique scheme preferably, Pedicellus et Pericarpium Trapae 50g, Herba Scutellariae Barbatae 1g and Herba Hedyotidis Diffusae 1g.
Technique scheme of the present invention proposes for serious three-hypers crowd.State in the use after pharmaceutical composition, multidigit has a patron of serious three-hypers symptom, and sb.'s illness took a favorable turn, stable, having taken continuously after 1 year, almost reaches the degree of radical cure.
Pharmaceutical composition of the present invention can adopt traditional decocting for Chinese herbal medicine means to use, and takes after mixing it with hot water after also can making Chinese medicine ultra-fine powder.
The present invention has following beneficial effect:
1. pharmaceutical composition of the present invention can be for prevention three-hypers;
2. pharmaceutical composition of the present invention can effect a radical cure three-hypers taking continuously after 1 year;
3. pharmaceutical composition of the present invention also has certain curative effect to cancer.
The specific embodiment
This specific embodiment is only explanation of the invention, is not limitation of the present invention.Any modification that those skilled in the art have done after having read description of the present invention, as long as in the protection domain of claims, all will be subject to the protection of Patent Law.
Embodiment mono-
For effecting a radical cure a pharmaceutical composition for three-hypers, formed by Pedicellus et Pericarpium Trapae 20g, Herba Scutellariae Barbatae 1g and Herba Hedyotidis Diffusae 1g.Pedicellus et Pericarpium Trapae can be one or more in Shell of Water Chestnut, water caltrop pulp, Pedicellus et Pericarpium Trapae rattan net.This pharmaceutical composition is used for preventing three-hypers.
Embodiment bis-
For effecting a radical cure a pharmaceutical composition for three-hypers, formed by Pedicellus et Pericarpium Trapae 20g, Herba Scutellariae Barbatae 0.5g and Herba Hedyotidis Diffusae 0.5g.Pedicellus et Pericarpium Trapae can be one or more in Shell of Water Chestnut, water caltrop pulp, Pedicellus et Pericarpium Trapae rattan net.This pharmaceutical composition is used for preventing three-hypers.
Embodiment tri-
For effecting a radical cure a pharmaceutical composition for three-hypers, formed by Pedicellus et Pericarpium Trapae 20g, Herba Scutellariae Barbatae 1g and Herba Hedyotidis Diffusae 1g.Pedicellus et Pericarpium Trapae can be one or more in Shell of Water Chestnut, water caltrop pulp, Pedicellus et Pericarpium Trapae rattan net.This pharmaceutical composition is used for preventing three-hypers.
Embodiment tetra-
For effecting a radical cure a pharmaceutical composition for three-hypers, formed by Pedicellus et Pericarpium Trapae 20g, Herba Scutellariae Barbatae 2g and Herba Hedyotidis Diffusae 2g.Pedicellus et Pericarpium Trapae can be one or more in Shell of Water Chestnut, water caltrop pulp, Pedicellus et Pericarpium Trapae rattan net.This pharmaceutical composition is used for preventing three-hypers.
Embodiment five
For effecting a radical cure a pharmaceutical composition for three-hypers, formed by Pedicellus et Pericarpium Trapae 50g, Herba Scutellariae Barbatae 1g and Herba Hedyotidis Diffusae 1g.Pedicellus et Pericarpium Trapae can be one or more in Shell of Water Chestnut, water caltrop pulp, Pedicellus et Pericarpium Trapae rattan net.This pharmaceutical composition is used for effecting a radical cure three-hypers.
Embodiment six
For effecting a radical cure a pharmaceutical composition for three-hypers, formed by Pedicellus et Pericarpium Trapae 50g, Herba Scutellariae Barbatae 0.5g and Herba Hedyotidis Diffusae 0.5g.Pedicellus et Pericarpium Trapae can be one or more in Shell of Water Chestnut, water caltrop pulp, Pedicellus et Pericarpium Trapae rattan net.This pharmaceutical composition is used for effecting a radical cure three-hypers.
Embodiment seven
For effecting a radical cure a pharmaceutical composition for three-hypers, formed by Pedicellus et Pericarpium Trapae 50g, Herba Scutellariae Barbatae 1g and Herba Hedyotidis Diffusae 1g.Pedicellus et Pericarpium Trapae can be one or more in Shell of Water Chestnut, water caltrop pulp, Pedicellus et Pericarpium Trapae rattan net.This pharmaceutical composition is used for effecting a radical cure three-hypers.
Embodiment eight
For effecting a radical cure a pharmaceutical composition for three-hypers, formed by Pedicellus et Pericarpium Trapae 50g, Herba Scutellariae Barbatae 2g and Herba Hedyotidis Diffusae 2g.Pedicellus et Pericarpium Trapae can be one or more in Shell of Water Chestnut, water caltrop pulp, Pedicellus et Pericarpium Trapae rattan net.This pharmaceutical composition is used for effecting a radical cure three-hypers.
Patient Wu, local peasant, because of dizziness unable hospitalized to have a thorough examination, 57 years old at that time, finds and suffer from hypertension, hyperglycemia, hyperlipidemia, and degree is very dark, the far super reference standard of every judge index, enters the later stage that three-hypers develops.Doctor outputs a large amount of Western medicine for controlling symptom, after this abandons the treatment of doctor trained in Western medicine because of economic cause, turns and seeks folk prescription among the people; After the chance encounter inventor, adopt the drug regimen composition formula as described in embodiment five, adhere to having used after 1 month, symptom alleviates to some extent, continues to take after one month, disease is controlled, because this pharmaceutical composition Financial cost is low and have certain curative effect suitable, Wu's long-term taking, adhered to after 1 year, symptom is improved completely, does not fall ill; Again after in hospital inspection, except hyperglycemia improve be not very obviously, other two height all return to normal person's level, its hyperglycemia also can be controlled in rational scope.
Patient wears certain, and 53 years old, Feng 61 years old, situation is almost consistent with Wu.
Patient poplar, 51 years old, local workman, participating in checking out three-hypers in the having regular physical checkups of factory, but degree was not very high, says to be exactly the mid-term of three-hypers with local proverb, does not fall ill at ordinary times, just slightly feels uncomfortable.Now inventor's the reputation about treatment three-hypers has had a certain impact power in locality, after learning, poplar is initiatively looked for inventor, adopt the pharmaceutical composition as shown in embodiment mono-, adhere to having taken after three months, patient feels well, in a routine physical examination, finds, indices has all returned to normal level.
Claims (10)
1. for effecting a radical cure a pharmaceutical composition for three-hypers, it is characterized in that being formed by Pedicellus et Pericarpium Trapae 15～25 weight portions, Herba Scutellariae Barbatae 0.5～2 weight portion and Herba Hedyotidis Diffusae 0.5～2 weight portion.
2. according to claim 1 a kind of for effecting a radical cure the pharmaceutical composition of three-hypers, it is characterized in that: Pedicellus et Pericarpium Trapae 18～22 weight portions, Herba Scutellariae Barbatae 0.8～1.5 weight portion and Herba Hedyotidis Diffusae 0.8～1.5 weight portion.
3. according to claim 1 a kind of for effecting a radical cure the pharmaceutical composition of three-hypers, it is characterized in that: Pedicellus et Pericarpium Trapae 19～21 weight portions, Herba Scutellariae Barbatae 0.8～1.2 weight portion and Herba Hedyotidis Diffusae 0.8～1.2 weight portion.
4. according to claim 1 a kind of for effecting a radical cure the pharmaceutical composition of three-hypers, it is characterized in that: Pedicellus et Pericarpium Trapae 20 weight portions, Herba Scutellariae Barbatae 1 weight portion and Herba Hedyotidis Diffusae 1 weight portion.
5. according to claim 1 a kind of for effecting a radical cure the pharmaceutical composition of three-hypers, it is characterized in that: Pedicellus et Pericarpium Trapae 20g, Herba Scutellariae Barbatae 1g and Herba Hedyotidis Diffusae 1g.
6. for effecting a radical cure a pharmaceutical composition for three-hypers, it is characterized in that being formed by Pedicellus et Pericarpium Trapae 45～55 weight portions, Herba Scutellariae Barbatae 0.5～2 weight portion and Herba Hedyotidis Diffusae 0.5～2 weight portion.
7. according to claim 6 a kind of for effecting a radical cure the pharmaceutical composition of three-hypers, it is characterized in that: Pedicellus et Pericarpium Trapae 48～52 weight portions, Herba Scutellariae Barbatae 0.8～1.5 weight portion and Herba Hedyotidis Diffusae 0.8～1.5 weight portion.
8. according to claim 6 a kind of for effecting a radical cure the pharmaceutical composition of three-hypers, it is characterized in that: Pedicellus et Pericarpium Trapae 49～51 weight portions, Herba Scutellariae Barbatae 0.8～1.2 weight portion and Herba Hedyotidis Diffusae 0.8～1.2 weight portion.
9. according to claim 6 a kind of for effecting a radical cure the pharmaceutical composition of three-hypers, it is characterized in that: Pedicellus et Pericarpium Trapae 50 weight portions, Herba Scutellariae Barbatae 1 weight portion and Herba Hedyotidis Diffusae 1 weight portion.
10. according to claim 6 a kind of for effecting a radical cure the pharmaceutical composition of three-hypers, it is characterized in that: Pedicellus et Pericarpium Trapae 50g, Herba Scutellariae Barbatae 1g and Herba Hedyotidis Diffusae 1g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410040736.1A CN103860699B (en) | 2014-01-28 | 2014-01-28 | A kind of pharmaceutical composition for effecting a radical cure three-hypers |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410040736.1A CN103860699B (en) | 2014-01-28 | 2014-01-28 | A kind of pharmaceutical composition for effecting a radical cure three-hypers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103860699A true CN103860699A (en) | 2014-06-18 |
| CN103860699B CN103860699B (en) | 2015-09-23 |
Family
ID=50900086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410040736.1A Expired - Fee Related CN103860699B (en) | 2014-01-28 | 2014-01-28 | A kind of pharmaceutical composition for effecting a radical cure three-hypers |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103860699B (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104041615A (en) * | 2014-06-28 | 2014-09-17 | 牟培锐 | Blood-pressure-lowering health tea |
| CN104107349A (en) * | 2014-07-01 | 2014-10-22 | 河南科技大学第一附属医院 | Chinese herbal medicine for three-hypers patients, and its administration method |
| CN104547960A (en) * | 2015-02-09 | 2015-04-29 | 王士国 | Qi tonifying and meridian unblocking medicament for patients with hyperlipidemia and preparation method of medicament |
| CN104606381A (en) * | 2015-01-07 | 2015-05-13 | 李建社 | Health soup and preparation method thereof |
| CN106074748A (en) * | 2016-08-24 | 2016-11-09 | 路明芳 | A kind of Chinese medicine treating diabetes |
| CN106511829A (en) * | 2016-10-25 | 2017-03-22 | 黄赵玲 | Yao medicine tub-bath preparation capable of reducing blood pressure, blood sugar and blood fat, and preparation method thereof |
| CN108200973A (en) * | 2018-02-22 | 2018-06-26 | 安徽中盛食用油科技有限公司 | A kind of reducing blood pressure and blood fat camellia oil and its processing method |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1085444A (en) * | 1993-07-08 | 1994-04-20 | 肖文生 | Chinese herbal medicine cancer-curing agent and its preparation method |
| CN1217931A (en) * | 1997-11-24 | 1999-06-02 | 赵文奇 | Medicines for various cancers |
| CN1294009A (en) * | 1999-10-28 | 2001-05-09 | 马金发 | Anticancer Chinese medicine and its preparing process |
| CN101683414A (en) * | 2008-09-25 | 2010-03-31 | 王继先 | Drug for treating cancers |
| KR101166884B1 (en) * | 2009-11-23 | 2012-07-18 | 주식회사 티제이네츄럴 | Composition of mixed herb medicine for leached tea |
-
2014
- 2014-01-28 CN CN201410040736.1A patent/CN103860699B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1085444A (en) * | 1993-07-08 | 1994-04-20 | 肖文生 | Chinese herbal medicine cancer-curing agent and its preparation method |
| CN1217931A (en) * | 1997-11-24 | 1999-06-02 | 赵文奇 | Medicines for various cancers |
| CN1294009A (en) * | 1999-10-28 | 2001-05-09 | 马金发 | Anticancer Chinese medicine and its preparing process |
| CN101683414A (en) * | 2008-09-25 | 2010-03-31 | 王继先 | Drug for treating cancers |
| KR101166884B1 (en) * | 2009-11-23 | 2012-07-18 | 주식회사 티제이네츄럴 | Composition of mixed herb medicine for leached tea |
Non-Patent Citations (3)
| Title |
|---|
| 佟永薇: "黄酮类化合物提取方法的研究及展望", 《食品研究与开发》 * |
| 董欢欢等: "半枝莲、白花蛇舌草及其药对提取物抗氧化及清除自由基活性", 《天然产物研究与开发》 * |
| 赵文亚: "菱角功能性成分研究进展", 《食品工程》 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104041615A (en) * | 2014-06-28 | 2014-09-17 | 牟培锐 | Blood-pressure-lowering health tea |
| CN104107349A (en) * | 2014-07-01 | 2014-10-22 | 河南科技大学第一附属医院 | Chinese herbal medicine for three-hypers patients, and its administration method |
| CN104606381A (en) * | 2015-01-07 | 2015-05-13 | 李建社 | Health soup and preparation method thereof |
| CN104547960A (en) * | 2015-02-09 | 2015-04-29 | 王士国 | Qi tonifying and meridian unblocking medicament for patients with hyperlipidemia and preparation method of medicament |
| CN106074748A (en) * | 2016-08-24 | 2016-11-09 | 路明芳 | A kind of Chinese medicine treating diabetes |
| CN106511829A (en) * | 2016-10-25 | 2017-03-22 | 黄赵玲 | Yao medicine tub-bath preparation capable of reducing blood pressure, blood sugar and blood fat, and preparation method thereof |
| CN108200973A (en) * | 2018-02-22 | 2018-06-26 | 安徽中盛食用油科技有限公司 | A kind of reducing blood pressure and blood fat camellia oil and its processing method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103860699B (en) | 2015-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103860699B (en) | A kind of pharmaceutical composition for effecting a radical cure three-hypers | |
| CN103784820B (en) | For treating Chinese medicine formula and the Chinese medicinal capsule of cardiovascular stasis coronary heart disease | |
| CN103520572A (en) | Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition | |
| CN108478731A (en) | Chinese medicine preparation and Chinese medicinal capsule for treating cardiovascular stasis coronary heart disease | |
| CN102100872A (en) | Chinese medicine preparation for treating mastitis | |
| CN102247479B (en) | Antitumor strong medicine and preparation method thereof | |
| CN102626443B (en) | Chinese herbal medicine combination for treating gout | |
| CN104587302A (en) | Traditional Chinese medicine preparation for treating acute appendicitis | |
| CN104288496A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN105943705A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN104147526A (en) | Traditional Chinese medicine particles for treating icteric hepatitis and preparation method thereof | |
| CN103446535B (en) | A kind of Miao Ethnomedicine for the treatment of coronary heart disease | |
| CN101549140B (en) | Traditional Chinese medicine composition for treating AIDS and preparation method thereof | |
| CN104940752A (en) | Chinese medicine preparation for treating vulva ulcer and preparing method thereof | |
| CN105561272A (en) | Traditional Chinese medicine preparation for relieving Reynolds disease and preparation method thereof | |
| CN105012552A (en) | Traditional Chinese medicine for treating wind-prevailing migratory arthralgia type rheumatic arthritis and preparation method | |
| CN105169278A (en) | Dandelion oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof | |
| CN104623532A (en) | Traditional Chinese medicine composition for treating glioma and preparation method thereof | |
| CN104740405B (en) | A kind of Chinese medicine preparation and preparation method for treating anaphylactoid purpura renal damage | |
| CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
| CN111214584B (en) | Traditional Chinese medicine composition for tonifying kidney and benefiting liver as well as preparation method and application thereof | |
| CN103071079A (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
| CN101401881B (en) | Chinese medicinal composition for treating poison produced by venomous insects | |
| CN106177075A (en) | The cold compress bag for the treatment of allergic skin and preparation method thereof | |
| CN101167915B (en) | Traditional Chinese medicine for treating chronic superficial gastritis and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150923 Termination date: 20180128 |